"Cardiomyopathy with systolic heart failure is the leading cause of death and lower LVEF is an independent predictor of mortality at younger ages in patients with DMD." (ref: https://openres.ersjournals.com/content/9/5/00176-2023)
The Demographics (DM) domain is used to represent information about the participants in a clinical study. Note there are 4 participants in this DM dataset; test results are shown for 1 participant.
dm.xpt
dm.xpt
Row
STUDYID
DOMAIN
USUBJID
SUBJID
RFSTDTC
RFENDTC
RFXSTDTC
RFXENDTC
RFICDTC
RFPENDTC
DTHDTC
DTHFL
SITEID
BRTHDTC
AGE
AGEU
SEX
RACE
ARMCD
ARM
ACTARMCD
ACTARM
ARMNRS
ACTARMUD
COUNTRY
1
DMD-EF
DM
DMD-EF-01-101
101
2022-05-16T09:00
2022-05-16
01
2010-02-07
12
YEARS
M
BLACK OR AFRICAN AMERICAN
A
Drug A
A
Drug A
USA
2
DMD-EF
DM
DMD-EF-01-102
102
2022-06-13T08:00
2022-06-13
01
2008-05-01
14
YEARS
M
ASIAN
A
Drug A
A
Drug A
MYS
3
DMD-EF
DM
DMD-EF-01-103
103
2022-07-15T10:15
2022-07-15
01
2003-07-10
19
YEARS
M
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
B
Drug B
B
Drug B
BRA
4
DMD-EF
DM
DMD-EF-01-104
104
2022-09-06T09:30
2022-09-06
2023-11-23
Y
01
1999-01-15
23
YEARS
M
WHITE
B
Drug B
B
Drug B
IRL
$warningHtml
It is important to record the height and weight for patients with DMD since cardiac index and spirometry results are affected by body surface area.[2] The Vital Signs (VS) dataset contains measurements including but not limited to blood pressure, temperature, respiration, body surface area, body mass index, height, and weight. The height in the population may be estimated from the ulna length measuring between the point of the elbow and the midpoint of the prominent bone of the wrist.
vs.xpt
vs.xpt
Row
STUDYID
DOMAIN
USUBJID
VSSEQ
VSTESTCD
VSTEST
VSPOS
VSORRES
VSORRESU
VSSTRESC
VSSTRESN
VSSTRESU
VSLOBFXL
VISITNUM
VISIT
VSDTC
1
DMD-EF
VS
DMD-EF-01-101
1
HEIGHT
Height
STANDING
47
in
119
119
cm
1
VISIT 1
2022-05-16
2
DMD-EF
VS
DMD-EF-01-101
2
WEIGHT
Weight
STANDING
20
kg
20
20
kg
1
VISIT 1
2022-05-16
3
DMD-EF
VS
DMD-EF-01-101
3
HEIGHT
Height
STANDING
52
in
132
132
cm
6
VISIT 6
2023-04-06
4
DMD-EF
VS
DMD-EF-01-101
4
WEIGHT
Weight
STANDING
32
kg
32
32
kg
6
VISIT 6
2023-04-06
$warningHtml
The Cardiovascular System Findings (CV) domain contains physiological and morphological findings related to the cardiovascular system.
Rows 1-8:
Show the baseline CMR ejection fraction measurements for the participant at visit 1.
Rows 9-16:
Show the CMR ejection fraction measurements for the participant at visit 6.
cv.xpt
cv.xpt
Row
STUDYID
DOMAIN
USUBJID
CVSEQ
CVLNKID
CVTESTCD
CVTEST
CVORRES
CVORRESU
CVSTRESC
CVSTRESN
CVSTRESU
CVLOC
CVMETHOD
CVLOBXFL
VISITNUM
VISIT
CVDTC
CVDY
1
DMD-EF
CV
DMD-EF-01-101
1
ESV
End Systolic Volume
32
mL
32
32
mL
HEART, LEFT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
2
DMD-EF
CV
DMD-EF-01-101
2
EDV
End Diastolic Volume
95
mL
95
95
mL
HEART, LEFT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
3
DMD-EF
CV
DMD-EF-01-101
3
2-1
LVEF_C
Left Ventricular Ejection Fraction, Cal
70
%
70
70
%
HEART, LEFT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
4
DMD-EF
CV
DMD-EF-01-101
4
2-1
CARDOUT
Cardiac Output
5.4
L/min
5.4
5.4
L/min
HEART, LEFT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
5
DMD-EF
CV
DMD-EF-01-101
5
ESV
End Systolic Volume
24
mL
24
24
mL
HEART, RIGHT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
6
DMD-EF
CV
DMD-EF-01-101
6
EDV
End Diastolic Volume
90
mL
90
90
mL
HEART, RIGHT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
7
DMD-EF
CV
DMD-EF-01-101
7
2-1
RVEF_C
Right Ventricular Ejection Fraction, Cal
75
%
75
75
%
HEART, RIGHT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
8
DMD-EF
CV
DMD-EF-01-101
8
2-1
CARDOUT
Cardiac Output
5.6
L/min
5.6
5.6
L/min
HEART, RIGHT VENTRICLE
MRI
1
VISIT 1
2022-05-16
1
9
DMD-EF
CV
DMD-EF-01-101
9
ESV
End Systolic Volume
37
mL
37
37
mL
HEART, LEFT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
10
DMD-EF
CV
DMD-EF-01-101
10
EDV
End Diastolic Volume
94
mL
94
94
mL
HEART, LEFT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
11
DMD-EF
CV
DMD-EF-01-101
11
2-2
LVEF_C
Left Ventricular Ejection Fraction, Cal
65
%
65
65
%
HEART, LEFT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
12
DMD-EF
CV
DMD-EF-01-101
12
2-2
CARDOUT
Cardiac Output
4.0
L/min
4.0
4.0
L/min
HEART, LEFT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
13
DMD-EF
CV
DMD-EF-01-101
13
ESV
End Systolic Volume
36
mL
36
36
mL
HEART, RIGHT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
14
DMD-EF
CV
DMD-EF-01-101
14
EDV
End Diastolic Volume
93
mL
93
93
mL
HEART, RIGHT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
15
DMD-EF
CV
DMD-EF-01-101
15
2-2
RVEF_C
Right Ventricular Ejection Fraction, Cal
70
%
70
70
%
HEART, RIGHT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
16
DMD-EF
CV
DMD-EF-01-101
16
2-2
CARDOUT
Cardiac Output
4.0
L/min
4.0
4.0
L/min
HEART, RIGHT VENTRICLE
MRI
6
VISIT 6
2023-04-06
326
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
The lab test, N-terminal pro-B-type natriuretic peptide (NT-proBNP), is a biomarker used in heart failure and ejection fraction for diagnosis and treatment.[3,4] These test results are represented in the Laboratory Test Results (LB) domain.
Row 1:
Shows the results for the NT-proBNP test at visit 1.
Row 2:
Shows the results for the NT-proBNP test at visit 6.
lb.xpt
lb.xpt
Row
STUDYID
DOMAIN
USUBJID
LBSEQ
LBLNKID
LBTESTCD
LBTEST
LBCAT
LBORRES
LBORRESU
LBORNRLO
LBORNRHI
LBSTRESC
LBSTRESN
LBSTRESU
LBSTNRLO
LBSTRNHI
LBNRIND
LBLOINC
LBSPEC
LBLOBXFL
VISITNUM
VISIT
LBDTC
LBDY
1
DMD-EF
LB
DMD-EF-01-101
1
2-1
BNPPRONT
N-Terminal ProB-type Natriuretic Peptide
CHEMISTRY
40
pg/mL
0
100
40
40
ng/L
0
100
NORMAL
71425-3
BLOOD
1
VISIT 1
2022-05-16
1
2
DMD-EF
LB
DMD-EF-01-101
2
2-2
BNPPRONT
N-Terminal ProB-type Natriuretic Peptide
CHEMISTRY
900
pg/mL
0
100
900
900
ng/L
0
100
HIGH
71425-3
BLOOD
6
VISIT 6
2023-04-06
326
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
A Related Records (RELREC) dataset is used to show the relationship between the CV and LB domains.TAUGDMDCIS-18
-
Getting issue details...STATUSTAUGDMDCIS-19
-
Getting issue details...STATUS
$titleHtml
relrec.xpt
Row
STUDYID
RDOMAIN
USUBJID
IDVAR
IDVARVAL
RELTYPE
RELID
1
DMD-EF
CV
CVLNKID
MANY
2
2
DMD-EF
LB
LBLNKID
ONE
2
$warningHtml
For patients with DMD, it is important to ensure the height and weight are current since cardiac index and spirometry results are affected by body surface area (ref: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.115.003810). Height and weight are represented in the vital signs domain; see Section 6.3.13 of the SDTMIG v3.4 (https://www.cdisc.org/standards/foundational/sdtmig) for more information. The patient's age also plays a role in the assessment analysis. Age is represented in the demographics domain; see Section 5.2 of the SDTMIG v3.4 (https://www.cdisc.org/standards/foundational/sdtmig). At the point of the study, the age may be collected or referenced.